Withdrawn from the market (safety)
Pronunciation: SIS-a-pride
Mechanism of action: Cisapride ballicule
What it is5-HT4 agonist prokinetic; withdrawn.
Why this oneIt was the most effective prokinetic for gastroparesis and reflux.
What limits itWithdrawn for fatal QT arrhythmias, particularly with CYP3A4 inhibitors — the case that taught the field about drug-induced torsades.
Molecular structure: Cisapride
FDA-approved for
- GERD (1993 — US market withdrawn 2000, limited-access only)
⚠ BOXED WARNING
- Serious cardiac arrhythmias including torsades
Classes and tags
Clinical profile
Therapeutic safety burden3 / 4
QT / Torsades4 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4
Legacy pregnancy categoryC
Defining liabilityQT prolongation and potentially fatal ventricular arrhythmia
Open Cisapride in the interactive console ↗